Princess Margaret Hospital
Toronto, ON, Canada
Dr. Scott Bratman is the Dr. Mariano Antonio Elia Chair in Head and Neck Cancer Research at University Health Network, Staff Radiation Oncologist at Princess Margaret Cancer Centre, and Associate Professor at University of Toronto. He serves as Co-Chair of the Head and Neck Disease Site Group at Canadian Cancer Trials Group (CCTG). Dr. Bratman is known for his contributions to novel liquid biopsy methods with immense scientific and clinical impact. His ground-breaking research has produced fundamental discoveries in cell-free DNA biology with implications for precision medicine and response monitoring in oncology. The Bratman Lab at the Princess Margaret Cancer Research Institute looks to accelerate discoveries in head and neck cancer biology, dynamic biomarkers, and risk-adapted therapy. Dr. Bratman holds a BA from Princeton University and an MD/PhD from Columbia University.
Disclosures:
Blood-Based Biomarkers for Early Cancer Detection
Sunday, September 29, 2024
4:47 PM – 5:02 PM ET
SS 19 - Bio 3: Genomics and Biomarkers
Monday, September 30, 2024
10:45 AM – 12:00 PM ET
Tuesday, October 1, 2024
3:00 PM – 3:10 PM ET